GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Monogram Orthopaedics Inc (NAS:MGRM) » Definitions » EPS (Diluted)

Monogram Orthopaedics (Monogram Orthopaedics) EPS (Diluted) : $-0.52 (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Monogram Orthopaedics EPS (Diluted)?

Monogram Orthopaedics's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $-0.09. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.52.

Monogram Orthopaedics's EPS (Basic) for the three months ended in Dec. 2023 was $-0.09. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.52.

Monogram Orthopaedics's EPS without NRI for the three months ended in Dec. 2023 was $-0.09. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.63.

During the past 3 years, the average EPS without NRIGrowth Rate was -50.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was -93.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Monogram Orthopaedics's highest 3-Year average EPS without NRI Growth Rate was -50.80% per year. The lowest was -143.50% per year. And the median was -98.70% per year.


Monogram Orthopaedics EPS (Diluted) Historical Data

The historical data trend for Monogram Orthopaedics's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monogram Orthopaedics EPS (Diluted) Chart

Monogram Orthopaedics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial -0.06 -0.29 -0.38 -0.44 -0.61

Monogram Orthopaedics Quarterly Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 -0.13 -0.27 -0.03 -0.09

Competitive Comparison of Monogram Orthopaedics's EPS (Diluted)

For the Medical Devices subindustry, Monogram Orthopaedics's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Monogram Orthopaedics's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Monogram Orthopaedics's PE Ratio distribution charts can be found below:

* The bar in red indicates where Monogram Orthopaedics's PE Ratio falls into.



Monogram Orthopaedics EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Monogram Orthopaedics's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-13.745-0)/22.409
=-0.61

Monogram Orthopaedics's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-3.654-0)/31.189
=-0.12

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Monogram Orthopaedics  (NAS:MGRM) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Monogram Orthopaedics EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Monogram Orthopaedics's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Monogram Orthopaedics (Monogram Orthopaedics) Business Description

Traded in Other Exchanges
Address
3913 Todd Lane, Suite 307, Austin, TX, USA, 78744
Monogram Orthopaedics Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
Executives
Paul H Riss director
Noel Knape officer: Chief Financial Officer 3913 TODD LANE, AUSTIN TX 78744
Benjamin Sexson director, 10 percent owner, officer: Chief Executive Officer 3913 TODD LANE, AUSTIN TX 78744
Noel Goddard director 3913 TODD LANE, AUSTIN TX 78744
Kamran Shamaei officer: Chief Technology Officer 3913 TODD LANE, AUSTIN TX 78744
Douglas Unis director 3913 TODD LANE, AUSTIN TX 78744